Insider · CIK 0001775490
Shoshana Shendelman
Files at APLT (Applied Therapeutics, Inc.). First filing Dec 1, 2023, latest Jun 10, 2024.
In brief
Shoshana Shendelman files SEC Form 4 as CEO, president, director and 10% owner at APLT (Applied Therapeutics, Inc.). Since Dec 1, 2023, Shoshana Shendelman has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.0M, the latest filed on Jun 10, 2024.
A track record needs three past buys with six months of prices behind them; Shoshana Shendelman has 0, so none is measured yet.
The newest scored trade: sold $267k of APLT on Jun 6, 2024, filed Jun 10, 2024, scored 53 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Applied Therapeutics, Inc. | $267k 61,795 shares | -2% | - | |
| 65Notable | Applied Therapeutics, Inc. | $1.7M 318,573 shares | -8% | - | |
| 40Moderate | Applied Therapeutics, Inc. | $7,817 3,968 shares | -0% | - |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 6, 2024 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stock | -61,795 | $4.32 | $267k | 3,756,019 | Jun 10, 2024 |
| Mar 14, 2024 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stock | -318,573 | $5.39 | $1.7M | 3,817,814 | Mar 18, 2024 |
| Dec 21, 2023 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +1,100,000 | $0.00 | $0 | 3,696,387 | Dec 22, 2023 |
| Dec 21, 2023 | APLT Applied Therapeutics, Inc. | AGrant or award Common Stock | +440,000 | $0.00 | $0 | 4,136,387 | Dec 22, 2023 |
| Nov 30, 2023 | APLT Applied Therapeutics, Inc. | SOpen-market sale Common Stock | -3,968 | $1.97 | $7,817 | 2,596,387 | Dec 1, 2023 |
Questions about Shoshana Shendelman
Answered from the filings on this page, as of the latest one.
Is Shoshana Shendelman buying or selling?
Not in the last 12 months. Shoshana Shendelman's latest open-market trade on SEC Form 4 was sold $267k of APLT on Jun 6, 2024.
How did Shoshana Shendelman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shoshana Shendelman has 0.
Where does Shoshana Shendelman file Form 4?
Shoshana Shendelman has filed Form 4 at APLT (Applied Therapeutics, Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.